Upcoming Events

Member Rate applies for MassBio Member Company, Other State Bioscience Association Member Company, MassCONNECT Company, or Unemployed Individual Description Science of Biotech 101 is designed for the non-scientist. The class acts as a survey of the basic biological processes that are foundational to the biopharma and life sciences industry. Participants will apply their new understanding of basic cell and molecular biology to the work of life sciences companies that research and develop therapies and products to improve lives, enhance agriculture,…

Massachusetts Institute of Technology, in collaboration with University College London, is announcing its 2021 Vaccines BioProcess Development & Commercialization Workshop. This three-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years' experience in their field will lead delegates in developing their understanding in the research, development, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will…

Celebrate the enduring legacy of cancer research at MIT. Current and former directors reflect on the past five decades of progress—from seminal discoveries in molecular biology and immunology to new innovations in nanotechnology and precision medicine—and look ahead to future advancements in the fight against cancer. Join in the conversation as we commemorate the people, projects, and promise of integrative cancer research. Featuring Phillip Sharp, PhD Director: 1985–1991 Institute Professor and Professor of Biology Richard Hynes, PhD Director: 1991–2001 Daniel…

Joe Corkery, MD will discuss his personal journey along the intersection of health care and technology from his perspectives as a physician as well as a technology product leader at Google. In particular, he will highlight key insights about health care that technology leaders need to understand, and conversely, key learnings for health care practitioners about the technology industry.

Join Us!! Featuring Keynote presentations from Professor Bruce Levine of the University of Pennsylvania and Dr. Peter Marks of USFDA. The first FDA-approved cell and gene therapies revolutionized healthcare by bringing novel medicines to patient populations who lacked other treatment options. Progress is needed on multiple fronts to extend the application of these innovative product modalities to new patient populations and disease indications. MIT CBI’s BioMAN Consortium will host the 2021 BioMAN Summit, which brings together thought leaders from industry,…

Hear ten medical device startups selected for the IMPACT Accelerator Program pitch their innovation to a panel of investors. Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, and Life Sciences Industry Professionals: Join the worldwide life sciences community as the startups from the Cycle 1 Cohort pitch their medical device solution to a panel of judges. These startups have been working with M2D2, Asahi Intecc, and Boston Scientific to advance the commercialization of their innovation through the IMPACT Accelerator Program.…